Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: cedarbaum jm. Mov Disord. 2022 Jan;37(1):190-195. doi: 10.1002/mds.28792. Epub 2021 Sep 22. Mov Disord. 2022. PMID: 34550621 Free PMC article.
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning.
Mirelman A, Ben Or Frank M, Melamed M, Granovsky L, Nieuwboer A, Rochester L, Del Din S, Avanzino L, Pelosin E, Bloem BR, Della Croce U, Cereatti A, Bonato P, Camicioli R, Ellis T, Hamilton JL, Hass CJ, Almeida QJ, Inbal M, Thaler A, Shirvan J, Cedarbaum JM, Giladi N, Hausdorff JM. Mirelman A, et al. Among authors: cedarbaum jm. Mov Disord. 2021 Sep;36(9):2144-2155. doi: 10.1002/mds.28631. Epub 2021 May 6. Mov Disord. 2021. PMID: 33955603
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: cedarbaum jm. Mov Disord. 2022 Mar;37(3):651-652. doi: 10.1002/mds.28929. Epub 2022 Jan 22. Mov Disord. 2022. PMID: 35064687 No abstract available.
Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease.
Mirelman A, Hillel I, Rochester L, Del Din S, Bloem BR, Avanzino L, Nieuwboer A, Maidan I, Herman T, Thaler A, Gurevich T, Kestenbaum M, Orr-Urtreger A, Brys M, Cedarbaum JM, Giladi N, Hausdorff JM. Mirelman A, et al. Among authors: cedarbaum jm. Mov Disord. 2020 Jun;35(6):959-968. doi: 10.1002/mds.28006. Epub 2020 Feb 20. Mov Disord. 2020. PMID: 32080891
Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease.
Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Cedarbaum JM, Orr-Urtreger A, Shenhar-Tsarfaty S, Mirelman A. Thaler A, et al. Among authors: cedarbaum jm. J Neurol. 2021 Apr;268(4):1517-1525. doi: 10.1007/s00415-020-10325-4. Epub 2021 Jan 3. J Neurol. 2021. PMID: 33388928
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers.
Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Shirvan JC, Cedarbaum JM, Orr-Urtreger A, Regev K, Shenhar-Tsarfaty S, Mirelman A. Thaler A, et al. Among authors: cedarbaum jm. J Parkinsons Dis. 2021;11(3):1285-1296. doi: 10.3233/JPD-212624. J Parkinsons Dis. 2021. PMID: 33998549 Free PMC article.
151 results